Hula Therapeutics
Hula Therapeutics is an immunotherapy company spinout from the lab of Dr, John Maris at Children’s Hospital of Philadelphia (CHOP). Hula is leveraging deep expertise to identify unique, functionally relevant, and essential tumor specific targets and make them accessible to precision therapeutics (e.g. cell therapy, T-cell engagers, bi-specifics, antibody drug conjugates) for the treatment of adults and children with solid cancers.
Active Portfolio Company